Amdocs Limited
DOX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.42 | 1.75 | 0.20 | -0.74 |
| FCF Yield | 2.10% | 1.53% | 0.81% | 1.91% |
| EV / EBITDA | 42.30 | 44.17 | 41.51 | 94.20 |
| Quality | ||||
| ROIC | 3.25% | 3.49% | 3.17% | 1.92% |
| Gross Margin | 37.86% | 38.13% | 38.54% | 34.73% |
| Cash Conversion Ratio | 2.37 | 1.56 | 1.05 | 0.70 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.48% | -1.16% | 0.12% | 1.50% |
| Free Cash Flow Growth | 35.35% | 100.12% | -59.29% | 9.70% |
| Safety | ||||
| Net Debt / EBITDA | 2.27 | 2.21 | 2.36 | 3.98 |
| Interest Coverage | 17.30 | 23.36 | 31.02 | 12.20 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 23.70 | 31.78 | 38.02 | 39.85 |